Picture of Tempus AI logo

TEM — Tempus AI News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb

BRIEF-Tempus Expands Strategic Collaboration With Bristol Myers Squibb

- Tempus AI, Inc. TEM.O:

  • EXPANDS STRATEGIC COLLABORATION WITH BRISTOL MYERS SQUIBB

  • BMS WILL LICENSE MULTIMODAL ONCOLOGY DATA FROM CO THROUGH 2031 TO SUPPORT BIOLOGICAL & CLINICAL INSIGHT IDENTIFICATION

  • UNDER COLLABORATION BMS WILL GAIN ACCESS TO CO'S LENS PLATFORM, AN AI-FIRST, AGENTIC PLATFORM FOR ONCOLOGY DRUG DEVELOPMENT

Source text: ID:nBw438L4Pa

Further company coverage: TEM.O


((Reutersbriefs@thomsonreuters.com;))

Recent news on Tempus AI

See all news